(Nasdaq: BCTX) (TSX: BCT) BriaCell teams up with New York Cancer & Blood Specialists for Phase 3 study of Bria-IMT™ in advanced breast cancer. Together, pioneering new paths in cancer care at one of the nation’s leading cancer centers.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.